Clincosm LogoSign in Get a demo

acute leukemia of ambiguous lineage

Showing 1 - 9 of 9
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug,

Not yet recruiting
  • Acute Leukemia of Ambiguous Lineage
  • +8 more
  • Biospecimen Collection
  • +12 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 22, 2023

Acute Leukemia of Ambiguous Lineage Trial in Suzhou (Venetoclax, azactidine)

Recruiting
  • Acute Leukemia of Ambiguous Lineage
  • Suzhou, China
    The First Affliated Hospital of Soochow University
Jun 14, 2023

Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage Trial in Houston (Clofarabine,

Recruiting
  • Acute Bilineal Leukemia
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Acute Biphenotypic Leukemia, Acute Leukemia, Acute Leukemia of Ambiguous Lineage Trial in United States (radiation, drug,

Recruiting
  • Acute Biphenotypic Leukemia
  • +11 more
  • Total-Body Irradiation
  • +8 more
  • Los Angeles, California
  • +9 more
Aug 19, 2022

Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia, Myeloid Tumor Trial in Seattle (drug, biological, other)

Completed
Has Results
  • Acute Leukemia of Ambiguous Lineage
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Feb 23, 2022

Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia Trial in Worldwide

Active, not recruiting
Has Results
  • Acute Leukemia of Ambiguous Lineage
  • +2 more
  • Birmingham, Alabama
  • +173 more
Nov 16, 2021

Acute Leukemia of Ambiguous Lineage Trial in Tianjin (vincristine, daunorubicin, cyclophosphamide)

Not yet recruiting
  • Acute Leukemia of Ambiguous Lineage
  • Tianjin, Tianjin, China
    HBDH
Jun 17, 2020

Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia Trial in Atlanta, Seattle (Ex-Vivo Expanded Cord Blood Progenitor

Terminated
  • Acute Leukemia of Ambiguous Lineage
  • Acute Myeloid Leukemia
  • Ex-Vivo Expanded Cord Blood Progenitor Cell Infusion
  • +3 more
  • Atlanta, Georgia
  • +1 more
Feb 27, 2019

Relapsed/Refractory AML, Relapsed/Refractory ALL, Secondary AML/MDS Trial in Canada, United States (Plerixafor Dose Escalation)

Completed
  • Relapsed/Refractory AML
  • +5 more
  • Plerixafor Dose Escalation
  • Phoenix, Arizona
  • +8 more
Sep 5, 2018